Intracavernosal add-on therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intracavernosal add-on therapy, covering 2024-12-04 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors [Phase 2]